Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal

Go back to Leerink Reaffirms Neovasc (NVCN) at 'Outperform' Amid Boston Scientific Deal

Form 6-K NEOVASC INC For: Dec 02

December 2, 2016 7:50 AM EST

 

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More